Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients A Scorilas, A Karameris, N Arnogiannaki, A Ardavanis, P Bassilopoulos, ... British journal of cancer 84 (11), 1488-1496, 2001 | 315 | 2001 |
CRD-BP: a c-Myc mRNA stabilizing protein with an oncofetal pattern of expression. P Ioannidis, L Mahaira, A Papadopoulou, MR Teixeira, S Heim, ... Anticancer research 23 (3A), 2179-2183, 2003 | 119 | 2003 |
Curcumin analogues as possible anti-proliferative & anti-inflammatory agents AM Katsori, M Chatzopoulou, K Dimas, C Kontogiorgis, A Patsilinakos, ... European journal of medicinal chemistry 46 (7), 2722-2735, 2011 | 116 | 2011 |
Expression of oncofetal RNA‐binding protein CRD‐BP/IMP1 predicts clinical outcome in colon cancer E Dimitriadis, T Trangas, S Milatos, PG Foukas, I Gioulbasanis, N Courtis, ... International journal of cancer 121 (3), 486-494, 2007 | 89 | 2007 |
Labdane type diterpenes down-regulate the expression of c-Myc protein, but not of Bcl-2, in human leukemia T-cells undergoing apoptosis K Dimas, C Demetzos, V Vaos, P Ioannidis, T Trangas Leukemia research 25 (6), 449-454, 2001 | 85 | 2001 |
C‐MYC and IGF‐II mRNA‐binding protein (CRD‐BP/IMP‐1) in benign and malignant mesenchymal tumors P Ioannidis, T Trangas, E Dimitriadis, M Samiotaki, I Kyriazoglou, ... International journal of cancer 94 (4), 480-484, 2001 | 83 | 2001 |
8q24 Copy number gains and expression of the c‐myc mRNA stabilizing protein CRD‐BP in primary breast carcinomas P Ioannidis, L Mahaira, A Papadopoulou, MR Teixeira, S Heim, ... International journal of cancer 104 (1), 54-59, 2003 | 79 | 2003 |
Determination of c-myc amplification and overexpression in breast cancer patients: evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological … A Scorilas, T Trangas, J Yotis, C Pateras, M Talieri British journal of cancer 81 (8), 1385-1391, 1999 | 65 | 1999 |
Parallel overexpression and clinical significance of kallikrein-related peptidases 7 and 14 (KLK7 & KLK14) in colon cancer M Devetzi, T Trangas, A Scorilas, D Xynopoulos, M Talieri Thrombosis and haemostasis 109 (04), 716-725, 2013 | 64 | 2013 |
Expression of the RNA-binding protein CRD-BP in brain and non-small cell lung tumors P Ioannidis, C Kottaridi, E Dimitriadis, N Courtis, L Mahaira, M Talieri, ... Cancer letters 209 (2), 245-250, 2004 | 56 | 2004 |
Cinin hyperparathyroidism secondary to X-linked hypophosphatemic rickets: case report and brief literature review MP Yavropoulou, K Kotsa, AG Psarrakou, A Papazisi, T Tranga, S Ventis, ... Hormones 9, 274-278, 2010 | 55 | 2010 |
Cytogenetic profile of unknown primary tumors: clues for their pathogenesis and clinical management D Pantou, H Tsarouha, A Papadopoulou, L Mahaira, I Kyriazoglou, ... Neoplasia 5 (1), 23-31, 2003 | 47 | 2003 |
Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: a new independent prognostic marker in primary breast cancer A Scorilas, M Talieri, A Ardavanis, N Courtis, E Dimitriadis, J Yotis, ... Cancer research 60 (19), 5427-5433, 2000 | 45 | 2000 |
The polyadenylation inhibitor cordycepin (3′ dA) causes a decline in c-MYC mRNA levels without affecting c-MYC protein levels P Ioannidis, N Courtis, M Havredaki, E Michailakis, CM Tsiapalis, ... Oncogene 18 (1), 117-125, 1999 | 41 | 1999 |
Cytogenetic manifestations of multiple myeloma heterogeneity D Pantou, H Rizou, H Tsarouha, A Pouli, K Papanastasiou, M Stamatellou, ... Genes, chromosomes and cancer 42 (1), 44-57, 2005 | 37 | 2005 |
Predictive value of c-erbB-2 and cathepsin-D for Greek breast cancer patients using univariate and multivariate analysis A Scorilas, J Yotis, C Pateras, T Trangas, M Talieri Clinical cancer research 5 (4), 815-821, 1999 | 36 | 1999 |
Novel SYT–SSX fusion transcript variants in synovial sarcoma E Dimitriadis, D Rontogianni, A Kyriazoglou, A Takou, K Frangia, ... Cancer genetics and cytogenetics 195 (1), 54-58, 2009 | 34 | 2009 |
Polyadenylic acid polymerase activity in normal and leukemic human leukocytes T Trangas, N Courtis, GA Pangalis, HV Cosmides, C Ioannides, ... Cancer research 44 (9), 3691-3697, 1984 | 34 | 1984 |
Granulocyte colony-stimulating factor expression as a prognostic biomarker in non-small cell lung cancer GP Stathopoulos, A Armakolas, T Tranga, H Marinou, J Stathopoulos, ... Oncology reports 25 (6), 1541-1544, 2011 | 33 | 2011 |
Study of genetic and epigenetic alterations in urine samples as diagnostic markers for prostate cancer E Dimitriadis, T Kalogeropoulos, S Velaeti, S Sotiriou, E Vassiliou, ... Anticancer Research 33 (1), 191-197, 2013 | 32 | 2013 |